Biocept (BIOC) Stock Climbs After Being Granted A New Patent

Biocept BIOC Stock News

Biocept Inc (NASDAQ: BIOC) is heading up in the market this morning, trading on gains of more than 6%. The gains come after the company said that it has been granted a new patent. Here’s what’s going on:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

BIOC Stock Is Up On New Patent

In the press release, Biocept said that it has been granted Brazil Patent No. BR112013028296-7. The patent is titled, “METHODS FOR DETECTING NUCLEIC ACID SEQUENCE VARIANTS.”

In the release, BIOC said that the patnet provides IP protection for Switch-Blocker technology. This technology is the core of its Target Selector assay for ctDNA analysis using real-time PCR, Sanger Sequencing and next-generation sequencing.

Ultimately, the company said that its Switch-Blocker technology enriches patient specimens for oncogene mutations of interest. This results in ultra-high sensitivity and specificity for the detection of cancer-associated alternations.

This Switch-Blocker is designed to improve detection rates for rare genetic alterations. These include biomarkers in patients diagnosed with cancer. Ultimately, this technology helps physicians to make informed decisions for therapy selection and to monitor treatment response, progression or recurrence over time.

In a statement, Lyle Arnold, Ph.D., CSO at BIOC, had the following to offer:

The issuance of this patent further expands Biocept’s global intellectual property protection for rare mutation detection, which already includes the U.S., South Korea, China, Australia, Japan, and Europe. The Switch-Blocker technology makes possible the ultra-sensitive detection of rare genetic events, and is especially useful for detecting rare cancer-associated mutations and alterations for use in our liquid biopsy assays. This technology works seamlessly with our other technologies for blood collection and CTC capture and analysis.

The above statement was followed up by Michael Nall, President and CEO at BIOC. Here’s what he had to say:

We are pleased to be granted this Brazilian patent covering our Switch-Blocker technology, which increases our total patent portfolio to 39 as we continue to expand our global intellectual property protection.

This News Is Exciting

Ultimately, the news issued by Biocept today is incredibly exciting. After all, when it comes to the treatment of cancer, strong diagnostic tools are needed. The company’s Target Selector and Switch Blocker technologies give physicians the tools and information they need in order to properly care for their patients.

With that said, intellectual property is always important. Think about it, patents protect the company from competitors that may want to use their technology and offer products at lower costs, ultimately snuffing BIOC out.

That’s why Warren Buffett talks so much about an economic moat, about IP protection, and about companies that have something that no one else can do. With the patent news, BIOC is only strengthening its economic moat, making it a more and more attractive investment option.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.